Clinical Trial Update: Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the glimepiride/metformin combination (Glimetal) for endothelial dysfunction in patients with Type 2 diabetes mellitus has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimetal (glimepiride/metformin)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Endothelial Dysfunction, Diabetes Mellitus | Phase 4 | Status: COMPLETED